Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Towa2B is the global business-to-business (B2B) and CMO/CDMO business unit of Towa International, which serves as the international hub of the Japanese generic pharmaceutical leader Towa Pharmaceutical. Headquartered in Barcelona, Spain, Towa2B is responsible for the international out-licensing, distribution, and contract manufacturing of high-quality generic and value-added medicines in more than 40 countries outside of direct markets. The unit leverages Towa International's state-of-the-art manufacturing plant in Martorelles, Barcelona, which is one of Europe's largest facilities for controlled-release products and pellets, and features a newly expanded high-containment area for high-potency drugs. Towa2B offers comprehensive development and manufacturing services (CMO/CDMO) to third-party generic and innovator pharmaceutical companies, focusing on oral solids, oncology treatments, and complex formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Towa2B.